OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Leukotriene Receptor Antagonist Montelukast Reduces Alpha-Synuclein Load and Restores Memory in an Animal Model of Dementia with Lewy Bodies
Julia Marschallinger, Barbara Altendorfer, Edward Rockenstein, et al.
Neurotherapeutics (2020) Vol. 17, Iss. 3, pp. 1061-1074
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Cysteinyl leukotriene receptor 1 modulates retinal immune cells, vascularity and proteolytic activity in aged mice
Andreas Koller, Julia Preishuber‐Pflügl, Daniela Mayr, et al.
Aging (2025)
Open Access | Times Cited: 1

The Leukotriene Receptor Antagonist Montelukast as a Potential COVID-19 Therapeutic
Ludwig Aigner, Frank Pietrantonio, Diana M Bessa de Sousa, et al.
Frontiers in Molecular Biosciences (2020) Vol. 7
Open Access | Times Cited: 35

The Leukotriene Receptor Antagonist Montelukast Attenuates Neuroinflammation and Affects Cognition in Transgenic 5xFAD Mice
Johanna Michael, Julia Zirknitzer, Michael S. Unger, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 5, pp. 2782-2782
Open Access | Times Cited: 28

Asthma amplifies dementia risk: Evidence from CSF biomarkers and cognitive decline
Ajay Kumar Nair, Carol A. Van Hulle, Barbara B. Bendlin, et al.
Alzheimer s & Dementia Translational Research & Clinical Interventions (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 20

Leukotrienes vs. Montelukast—Activity, Metabolism, and Toxicity Hints for Repurposing
Cátia F. Marques, M. Matilde Marques, Gonçalo C. Justino
Pharmaceuticals (2022) Vol. 15, Iss. 9, pp. 1039-1039
Open Access | Times Cited: 19

Potential Effects of Leukotriene Receptor Antagonist Montelukast in Treatment of Neuroinflammation in Parkinson’s Disease
Johan Wallin, Per Svenningsson
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 5606-5606
Open Access | Times Cited: 21

MCC950 ameliorates the dementia symptom at the early age of line M83 mouse and reduces hippocampal α-synuclein accumulation
Yu Ren, Qing Wang, Ze-xian Yang, et al.
Biochemical and Biophysical Research Communications (2022) Vol. 611, pp. 23-30
Closed Access | Times Cited: 13

Montelukast Ameliorates Scopolamine-induced Alzheimer’s Disease: Role on Cholinergic Neurotransmission, Antioxidant Defence System, Neuroinflammation and Expression of BDNF
Bhavana Yerraguravagari, Naga Pavani Penchikala, Aravinda Sai Kolusu, et al.
CNS & Neurological Disorders - Drug Targets (2023) Vol. 23, Iss. 8, pp. 1040-1055
Closed Access | Times Cited: 7

Neuromodulatory Effects of Leukotriene receptor antagonists: A comprehensive review
Radhika Sood, Shailendra Anoopkumar‐Dukie, Santosh Rudrawar, et al.
European Journal of Pharmacology (2024) Vol. 978, pp. 176755-176755
Open Access | Times Cited: 2

Leukotriene receptor antagonist use and cognitive decline in normal cognition, mild cognitive impairment, and Alzheimer’s dementia
Lisa Y. Xiong, Michael Ouk, Che‐Yuan Wu, et al.
Alzheimer s Research & Therapy (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 15

Leukotriene Signaling as a Target in α-Synucleinopathies
Katharina Strempfl, Michael S. Unger, Stefanie Flunkert, et al.
Biomolecules (2022) Vol. 12, Iss. 3, pp. 346-346
Open Access | Times Cited: 10

Hidden Comorbidities in Asthma: A Perspective for a Personalized Approach
Matteo Maule, Bianca Olivieri, Gabriella Guarnieri, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 6, pp. 2294-2294
Open Access | Times Cited: 4

Leukotriene signaling as molecular correlate for cognitive heterogeneity in aging: an exploratory study
Heike Mrowetz, Mohamed H. Kotob, Jennifer Forster, et al.
Frontiers in Aging Neuroscience (2023) Vol. 15
Open Access | Times Cited: 4

Dynamic modelling and tristability analysis of misfolded α-synuclein degraded via autophagy in Parkinson's disease
Bojie Yang, Zhuoqin Yang, Heng Liu, et al.
Biosystems (2023) Vol. 233, pp. 105036-105036
Closed Access | Times Cited: 4

Interaction between α-Synuclein and Bioactive Lipids: Neurodegeneration, Disease Biomarkers and Emerging Therapies
Chiara Sanluca, P. Spagnolo, Romina Mancinelli, et al.
Metabolites (2024) Vol. 14, Iss. 7, pp. 352-352
Open Access | Times Cited: 1

The leukotriene receptor antagonist montelukast as a potential therapeutic adjuvant in multiple sclerosis – a review
Frank Pietrantonio, A. N. SERREQI, Horst Zerbe, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1

Cysteinyl Leukotriene Receptor Antagonism by Montelukast to Treat Visual Deficits
Amritha T. M. Seetharaman, Caroline Owens, Rajashekhar Gangaraju
Journal of Ocular Pharmacology and Therapeutics (2024)
Closed Access | Times Cited: 1

Improved Bioavailability of Montelukast through a Novel Oral Mucoadhesive Film in Humans and Mice
Johanna Michael, Diana Bessa de Sousa, Justin Conway, et al.
Pharmaceutics (2020) Vol. 13, Iss. 1, pp. 12-12
Open Access | Times Cited: 11

Cognitive Effects of Montelukast: A Pharmaco-EEG Study
Fabian Schwimmbeck, Wolfgang Staffen, Christopher Höhn, et al.
Brain Sciences (2021) Vol. 11, Iss. 5, pp. 547-547
Open Access | Times Cited: 7

Chronobiological activity of cysteinyl leukotriene receptor 1 during basal and induced autophagy in the ARPE-19 retinal pigment epithelial cell line
Andreas Koller, Julia Preishuber‐Pflügl, Christian Runge, et al.
Aging (2021) Vol. 13, Iss. 24, pp. 25670-25693
Open Access | Times Cited: 7

Improved bioavailability of montelukast through a novel oral mucoadhesive film in humans and mice
Johanna Michael, Diana Bessa de Sousa, Justin Conway, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 3

Inhibition of CysLTR1 reduces the levels of aggregated proteins in retinal pigment epithelial cells
Andreas Koller, Susanne M. Brunner, Julia Preishuber‐Pflügl, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 1

Montelukast: A Review of Articles on the Experimental Level
sara yassin assistant lecturer, Luma Ibrahim Khalel Al-Allaf
Annals of the College of Medicine Mosul/Annals of the College of Medecine (2023) Vol. 45, Iss. 2, pp. 227-236
Open Access

Page 1 - Next Page

Scroll to top